Feasibility and Reliability of Synchronized Non-invasive Intermittent Positive Pressure Ventilation in Preterm Infants After Birth (SenSyNoPP)

September 19, 2024 updated by: University Hospital Tuebingen
The aim of this prospective observational study (pilot study) is to test if synchronized noninvasive positive pressure ventilation (S-NIPPV) is feasible and works appropriately during transition from intrauterine to extrauterine life in very preterm infants in the delivery room.

Study Overview

Detailed Description

The study period will be the first 10 minutes after birth.

All patients will be non-invasively ventilated using an EVE NEO ventilator (CE 0482, Fritz Stephan GmbH, Gackenbach, Germany). A facemask will be used throughout the study period. Synchronization will be achieved using graseby capsule (Stephan, Vio Healthcare), which will be secured at the abdominal wall on the midaxillary line below the ribs. For the detection of spontaneous breaths respiratory induction plethysmography (RIP) is used. For this purpose, an extra small plethysmography belt (Sleepsense, Elgin, USA) is placed around the abdomen. The data of the plethysmography belts are processed and stored with the NewLifebox-XL (Advanced Life Diagnostics UG, Weener, Germany) and merged with the data from the ventilator for later evaluation.

Infants according to the clinician's assessment only needing CPAP will receive S-NIPPV with very low PIP levels. This enables to have enough ventilator breaths applied for analysis to obtain sufficient data about the synchronization rate of S-NIPPV in the delivery room and meanwhile consider the infant's safety by not applying high pressures where it might not be needed. The ventilator support settings will be PIP 10, PEEP 6 in the noninvasive pressure controlled assist control ventilation (nPC-ACV+) mode. In this mode every spontaneous breath is supported by a ventilator breath (if the triggering level is exceeded). The triggering level will be set at 0,5 to avoid autotriggering and unsupported breaths. The inspiratory time will be set at max. 0,3 sec. The backup ventilation rate is set at 60 per minute.The EVE NEO ventilator has in the nPC-ACV+ mode an option where the ventilator breaths are interrupted/stopped as soon as the graseby capsule detects a start of spontaneous expiration.

If the infant according to the clinician's assessment needs S-NIPPV (e.g. the infant is apnoeic, and/or heart rate is below 100 bpm), the pressure of S-NIPPV will be augmented to target PIP 20, PEEP 6 (unless clinical concerns require an adjustment). The respiratory support can be deescalated to PIP 10 once the clinician deems the higher pressure no longer necessary.

The following demographical characteristics will be collected from the patient charts (pseudonymized): gender, gestational age, birth weight, antenatal steroids, mode of delivery, reason for prematurity (prolong premature rupture of membrane, infection, pathologic CTG, pathological doppler, gestosis), time of cord clamping, umbilical cord pH, FiO2 requirement, APGAR.

The following interventions within the first 10 minutes after birth including the time will be noted: tactile stimulation, placement of an intravenous line, non-invasive surfactant administration, intubation, chest compression, administration of volume, catecholamine, blood or other medication.

Study Type

Observational

Enrollment (Actual)

10

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Baden-Wuerttemberg
      • Tuebingen, Baden-Wuerttemberg, Germany, 72076
        • University Hospital Tuebingen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Preterm infants born at University Hospital in Tübingen.

Description

Inclusion Criteria:

  • Preterm infants with a gestational age (GA) between 26 ≥ and < 32 weeks

Exclusion Criteria:

  • Major congenital malformations
  • Refused parental consent (prenatal parental consent is necessary)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Preterm infants with a gestational age (GA) between 26 ≥ and < 32 weeks
Synchronized noninvasive positive pressure ventilation during the first 10 minutes after birth.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Synchronisation rate
Time Frame: First 10 minutes after birth
Synchronisation rate (sensitivity/true positive rate) of S-NIPPV in the delivery room meaning the proportion of graseby triggered synchronized ventilator breaths with corresponding RIP signal related to all spontaneous breaths detected by RIP.
First 10 minutes after birth

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
False negative rate
Time Frame: First 10 minutes after birth
Proportion of non-synchronized ventilator breaths with corresponding RIP signal. This will be related to all spontaneous breaths detected by RIP.
First 10 minutes after birth
False positive rate
Time Frame: First 10 minutes after birth
Proportion of graseby triggered ventilator breaths without corresponding RIP signal. This will be related to all ventilator breaths without a corresponding RIP signal (i.e. movement artefacts).
First 10 minutes after birth
Proportion of artifacts
Time Frame: First 10 minutes after birth
Proportion of graseby triggered ventilator breaths without corresponding RIP signal. This will be related to all ventilator breaths.
First 10 minutes after birth
Specificity (true negative rate)
Time Frame: First 10 minutes after birth
Proportion of ventilator breaths without corresponding RIP signal and with no graseby signal (i.e. during an apnoea). This will be related to all ventilator breaths without a corresponding RIP signal.
First 10 minutes after birth
Proportion of back up breaths
Time Frame: First 10 minutes after birth
Proportion of ventilator breaths without corresponding RIP signal and with no graseby signal. This will be related to all ventilator breaths.
First 10 minutes after birth
Proportion of time of synchronised breaths, non-synchronized breaths, periods of apnoea and periods of movement artefacts occure within the first ten minutes of respiratory support.
Time Frame: First 10 minutes after birth
First 10 minutes after birth
Time until the graseby capsule is attached to the infant's abdomen and the proportion of infants in whom the graseby capsule is attached within the first two minutes after birth.
Time Frame: First 10 minutes after birth
First 10 minutes after birth
Proportion of time non invasive ventilator breaths will be applied.
Time Frame: First 10 minutes after birth
First 10 minutes after birth
Peak inspiratory pressure (PIP)
Time Frame: First 10 minutes after birth
First 10 minutes after birth
Positive end expiatory pressure (PEEP)
Time Frame: First 10 minutes after birth
First 10 minutes after birth
Mean airway pressure (MAP)
Time Frame: First 10 minutes after birth
First 10 minutes after birth
Td (time delay) graseby
Time Frame: First 10 minutes after birth
Time between the initial increase of the abdominal RIP curve and the initial increase of the graseby curve.
First 10 minutes after birth
Td (time delay) ventilator
Time Frame: First 10 minutes after birth
Time between the initial increase of the graseby curve and the beginning of the pressure curve.
First 10 minutes after birth
Ti ventilator
Time Frame: First 10 minutes after birth
Inspiratory time of a ventilator breath
First 10 minutes after birth
Ti RIP
Time Frame: First 10 minutes after birth
Inspiratory time of a spontaneous breath
First 10 minutes after birth
Ti excess
Time Frame: First 10 minutes after birth
Calculated: ((Ti ventilator - Ti RIP)/Ti RIP)) x 100
First 10 minutes after birth
Swing RIP
Time Frame: First 10 minutes after birth
Amplitude of the RIP curve calculated by subtracting the baseline RIP from the peak RIP curve, which is a surrogate parameter for the patient's respiratory effort.
First 10 minutes after birth
Number of tactile stimulations and other interventions on the patient
Time Frame: First 10 minutes after birth
Number of tactile stimulations and other interventions on the patient (e.g. placement of intravenous line, non-invasive administration of surfactant, intubation, chest compression) are documented by video analysis.
First 10 minutes after birth
Heart rate
Time Frame: First 10 minutes after birth
First 10 minutes after birth
Oxygen saturation
Time Frame: First 10 minutes after birth
First 10 minutes after birth
Fraction of inspired oxygen
Time Frame: First 10 minutes after birth
First 10 minutes after birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 22, 2022

Primary Completion (Actual)

October 11, 2023

Study Completion (Actual)

October 11, 2023

Study Registration Dates

First Submitted

April 20, 2022

First Submitted That Met QC Criteria

May 31, 2022

First Posted (Actual)

June 1, 2022

Study Record Updates

Last Update Posted (Actual)

September 23, 2024

Last Update Submitted That Met QC Criteria

September 19, 2024

Last Verified

April 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe